We are live on ! Find out more
AXN

Aoxing Pharmaceutical Company Inc.
AXN

Delisted

AXN was delisted on the 16th of October, 2017.

Back to rankings

6 hedge funds and large institutions have $195K invested in Aoxing Pharmaceutical Company Inc. in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,673% more capital invested

Capital invested by funds: $11K → $195K (+$184K)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more funds holding

Funds holding: 3 → 6 (+3)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$43.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$28.4K
3
Goldman Sachs
Goldman Sachs
New York
+$13.4K
4
Renaissance Technologies
Renaissance Technologies
New York
+$10.5K
5
Deutsche Bank
Deutsche Bank
Germany
+$73

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$7K

AXN Hedge Fund Activity: Q1 2015 in Review

6 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q1 2015, worth a combined $195K — up 1,673% from $11K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AXN positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $43.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $7K sold.

  • 6 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q1 2015, up from 3 in Q4 2014.
  • Funds reported $195K of Aoxing Pharmaceutical Company Inc. stock for Q1 2015, up 1,673% quarter-over-quarter.
  • 5 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q1 2015 and 2 closed out, a net change of +3 holders.
  • The largest Aoxing Pharmaceutical Company Inc. buyer in Q1 2015 was Virtu KCG Holdings, an estimated $43.4K added.
  • The largest Aoxing Pharmaceutical Company Inc. seller in Q1 2015 was Citadel Advisors, an estimated $7K sold.

Based on aggregated 13F filings for Q1 2015.